Should adult tetanus immunization be given as a single vaccination at age 65?
- 1 August 1993
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 8 (8) , 405-412
- https://doi.org/10.1007/bf02599616
Abstract
Objective: To compare three vaccination strategies for the prevention of adult tetanus. Each strategy includes childhood primary immunization and wound prophylaxis, and one of the following: 1) the currently recommended booster every ten years; 2) a single booster at 65 years of age; or 3) no intervention after age 6 except for wound prophylaxis. Methods: Cost-effectiveness analysis was used to compare the three different strategies. A Markov model, cycled annually from age 5 through age 85, was applied to each strategy to predict the incidence and costs of tetanus for the U.S. adult population.Results: The three strategies have very similar effects on life expectancy but different costs. Expressed incremental to no intervention after childhood primary immunization, the decennial booster strategy is least cost-effective, with a discounted incremental cost-effectiveness ratio of $143,138 per year of life saved compared with $4,527 for the single-booster strategy. Sensitivity analysis demonstrates that the decennial strategy is more effective but more costly over a wide range of model assumptions. Conclusions: The current policy of recommending tetanus booster vaccinations every ten years is effective but much more costly than a more easily implemented policy that also provides considerable protection against tetanus. The authors recommend forsaking decennial boosters in favor of a policy of including a single booster at age 65 along with other recommended health maintenance maneuvers reserved for that age.Keywords
This publication has 54 references indexed in Scilit:
- Book ReviewFoundations of Obstetric AnaesthesiaNew England Journal of Medicine, 1988
- Diphtheria in Immunized PopulationsNew England Journal of Medicine, 1988
- Diphtheria Outbreaks in Immunized PopulationsNew England Journal of Medicine, 1988
- Molecular Epidemiology of the 1984–1986 Outbreak of Diphtheria in SwedenNew England Journal of Medicine, 1988
- Clinical tetanus despite a protective level of toxin-neutralizing antibodyJAMA, 1986
- Adverse reactions to tetanus toxoidJAMA, 1982
- RESPONSE TO SINGLE DOSE OF TETANUS VACCINE IN SUBJECTS WITH NATURALLY ACQUIRED TETANUS ANTITOXINThe Lancet, 1981
- REACTIONS AFTER PLAIN AND ADSORBED TETANUS VACCINESThe Lancet, 1980
- Tetanus despite preexisting antitetanus antibodyPublished by American Medical Association (AMA) ,1978
- Active Immunization against Tetanus in ManEuropean Surgical Research, 1975